MSAC publishes agenda for October 2022 ESC meeting


22 June 2022 - The MSAC Secretariat has published a list of applications scheduled to be considered by the ESC on 6 - 7 October 2022.

The agenda currently has 12 items. Applications of note include:

  • 1675 – Whole genome sequencing for the diagnosis of mitochondrial disease
  • 1684 – Genetic testing for variants associated with haematological malignancies
  • 1691 – PromarkerD testing in patients with type 2 diabetes mellitus to determine the risk of developing diabetic kidney disease
  • 1707 – Measuring minimal residual disease in acute lymphoblastic leukaemia using next generation sequencing assays to guide treatment decision
  • 1721 – Small gene panel testing for non-small cell lung cancer
  • 1723 – Brexucabtagene autoleucel for relapsed or refractory adult B-precursor acute lymphoblastic lymphoma

Read ESC agenda

Michael Wonder

Posted by:

Michael Wonder